Phase III randomized study comparing 5 or 10 μg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies-Reference-Cited by-同舟云学术

Phase III randomized study comparing 5 or 10 μg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies

Published:2003-01 Issue:1 Volume:43 Page:50-57
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

André Marc,Baudoux Etienne,Bron Dominique,Canon Jean-Luc,D'Hondt Véronique,Fassotte Marie-France,D'Hondt Lionel,Fillet Georges,Humblet Yves,Jerusalem Guy,Vermeulen Philippe,Symann Michel,Beguin Yves

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1537-2995.2003.00273.x/fullpdf

Reference24 articles.

1. Preclinical studies and clinical correlation of the effect of alkylating dose.;Frei;Cancer Res,1988

2. Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer.;Hryniuk;J Clin Oncol,1986

3. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma.;Philip;N Engl J Med,1995

4. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients.;Schmitz;Lancet,1996

5. Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies: the number of CD34+ cells reinfused is the only factor predicting both granulocyte and platelet recovery.;Faucher;J Hematother,1996

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison Between Standard and High Dose of G-CSF for Mobilization of Hematopoietic Progenitors Cells in Patients and Healthy Donors;Transfusion Medicine Reviews;2022-07

2. Hematopoietic stem cell mobilization strategies to support high-dose chemotherapy: A focus on relapsed/refractory germ cell tumors;World Journal of Clinical Oncology;2021-09-24

3. Prediction of Stem Cell Mobilization Failure in Patients with Hodgkin and Non-Hodgkin Lymphoma;Turkish Journal of Hematology;2020-11-09

4. A randomized evaluation of vinorelbine versus gemcitabine chemotherapy mobilization of stem cells in myeloma patients;Bone Marrow Transplantation;2020-03-25

5. Assessment of haematopoietic progenitor cell counting with the Sysmex? XN-1000 to guide timing of apheresis of peripheral blood stem cells;BLOOD TRANSFUS-ITALY;2020